Digital Health
Deep Forest Sciences Enters Into Partnership With Third Rock Ventures for Drug Discovery Machine Learning
Deep Forest Sciences,a startup that accelerates chemical matter discovery and optimization is partnering with Third Rock Ventures, a leading healthcare…
Deep Forest Sciences,a startup that accelerates chemical matter discovery and optimization is partnering with Third Rock Ventures, a leading healthcare venture firm. The partnership will provide Third Rock Ventures’ portfolio companies with unique access to Deep Forest’s scientific expertise and Chiron platform, which is a new machine learning toolkit that accelerates drug discovery by building upon the widely used DeepChem open-source project.
“We are excited to partner with Third Rock Ventures. We believe that Chiron can add significant value to drug discovery teams. Our cutting-edge machine learning tools will significantly reduce the time and cost of drug discovery and other ground-breaking scientific research,” remarked Dr. Bharath Ramsundar, Founder and CEO of Deep Forest Sciences.
Recommended AI: aelf Announces the form of aelf DAO, Enhancing Decentralization of Governance and Ecosystem Growth
“This partnership with Deep Forest will allow our incubating companies and portfolio companies to leverage the machine learning methods being developed by Deep Forest Sciences,” said Aaron Arvey, Ph.D., Director of Machine Learning at Third Rock Ventures. “Deep Forest’s platform will enable drug hunters across our portfolio to leverage the latest tools in their pursuit to improve patient lives.”
Recommended AI: Himax Partners with Novatek to Unveil Industry Leading Ultralow Power Pre-Roll AI Solution for Battery Surveillance Camera
Dr. Ramsundar is the founder and lead developer of the popular DeepChem open source framework which facilitates the use of AI in drug discovery. Deep Forest Sciences’s Chiron platform grew out of his efforts to build the open source foundations of DeepChem into suitable infrastructure for commercial drug discovery efforts. Chiron adds proprietary features including scaled infrastructure support and custom scientific foundation models which will enable AI to make headway into the challenging low data settings prevalent in real world drug discovery
Recommended AI: GoodFirms Unlocks the Best Task Management Software with Rich Features
[To share your insights with us, please write to sghosh@martechseries.com]
The post Deep Forest Sciences Enters Into Partnership With Third Rock Ventures for Drug Discovery Machine Learning appeared first on AiThority.
Keep it Short
By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Seattle startup Olamedi building platform to automate health clinic communications
A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…
